Our Clients

VPG services clients from a variety of backgrounds. Many of them to date are companies involved with biotechnology and various scientific industries. Some of our most recent clients include:

 

Mimotopes-TinyRes

Mimotopes Pty Ltd

One of the pioneers in combinatorial chemistry, Mimotopes developed a highly innovative and unique solid phase polymer technology to create libraries of small molecules and peptides for drug discovery research.

RDDT-Laboratories-LoRes

RDDT Laboratories

RDDT is a privately owned GLP compliant preclinical safety testing service based in Melbourne, Australia. Their GLP-compliant facility is equipped to perform a range of supporting safety studies in various mammalian species to the appropriate regulatory requirements.

AOQ-TinyRes

The Australian Organisation for Quality

The Australian Organisation for Quality Inc (AOQ) is Australia's Peak Professional Body for Quality practitioners and anyone interested in continual improvement in business leading to excellence in products and services.

Epichem-TinyRes

Epichem Pty Ltd

Epichem is a quality contract chemical research company providing discovery research, pharmaceutical standards, and scaffolds and intermediates.

PLP-logo-colour-3D-Tiny

Pacific Laboratory Products

Originally a division of Radiometer Pacific, PLP emerged as a separate entity in 2005 and continues to provide premium laboratory equipment and consumables.

Sullivan-logo-Tiny

O'Sullivan Health Foods

O’Sullivan Health Foods at Northbridge NSW are passionate about delivering wellness to their community.  This is the driving force behind every aspect of their store from sourcing superior quality products to providing unparalleled service.

MGH-TinyRes

My Global Hunter

My Global Hunter are a retailer who source hand made exclusive jewllery from around the world.

Apollo-TinyRes

Apollo Life Sciences

Apollo Life Sciences is an innovative biotechnology company making breakthroughs in the areas of drug delivery and expression of proteins from human cells. Apollo's combined technologies are expected to lead to more effective and lower cost therapeutics.


http://www.